IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#2876
Positioning
Market Dominance
Services
Healthcare
$765M
Tom Pike
Fortrea is a leading global contract research organization (CRO) helping customers bring life-changing solutions to patients faster. With over 19,000 professionals conducting operations in more than 90 countries, Fortrea is transforming drug and device development for partners and patients across the globe.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = FTRE ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | 21.3% | 18.6% | 64.5% | 35.7% | 39.5% | 6.5% | 0.0% | 0.0x | $644M | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | 15.4% | 12.6% | 38.7% | 17.1% | 17.0% | -39.7% | 0.0% | 0.0x | $439M | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 28.1% | 16.8% | 48.1% | 23.8% | 18.5% | 78.6% | 0.0% | 37.0x | $220M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | 12.4% | 2.9% | 100.0% | 28.2% | 26.2% | 5.5% | 0.8% | 264.0x | $19.4B | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.6% | 7.8% | 43.8% | 7.4% | 5.9% | 31.2% | 0.0% | 0.0x | $857M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 18.0% | 4.6% | 97.3% | 52.2% | 32.7% | -3.4% | 0.0% | 271.0x | $8.0B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | 9.4% | 4.9% | 55.5% | 8.7% | 7.7% | 13.6% | 1.3% | 7.0x | $78.0B | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | 22.1% | 15.6% | 62.5% | 28.1% | 28.7% | -1.0% | 2.8% | 9.0x | $56.6B | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 21.4% | 8.0% | 100.0% | 10.0% | 7.5% | 14.1% | 0.0% | 27.0x | $1.8B | VS | |
$FTRE Fortrea Holdings Inc. | 45 | 36 | 51 | 75 | - | 23.1x | -169.0% | -35.8% | 22.0% | -32.6% | -36.4% | 5.9% | 0.0% | 372.0x | $765M | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.3% | 1.9% | 59.6% | 3.5% | 2.3% | 7.8% | 0.0% | 0.3x | - | REF |
Fortrea Holdings Inc. (FTRE) receives a "Reduce" rating with a composite score of 44.6/100. It ranks #2876 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Tom Pike
Chief Executive Officer
36
31
22
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for FTRE
Outperforming peers — winners tend to keep winning over 3-12 months
Fair valuation relative to peers
Average quality profile
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for FTRE.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 36 | 26 | +10ALPHA |
| MOMENTUM | 75 | 84 | -9DRAG |
| VALUATION | 51 | 54 | -3NEUTRAL |
| INVESTMENT | 31 | 35 | -4NEUTRAL |
| STABILITY | 22 | 12 | +10ALPHA |
| SHORT INT | 20 | 5 | +15ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -0.7% vs WACC 6.7% (spread -7.4%)
GM 22% vs sector 60%, OM -33% vs sector 4%
Capital turnover 0.70x
Rev growth 6%, 3yr history
Interest coverage N/A, Net debt/EBITDA 90.5x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Fortrea Holdings Inc. receives a Reduce rating from our analysis, with a composite score of 44.6/100 and 2 out of 5 stars, ranking #2876 out of 7,333 stocks. FTRE's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
FTRE's quality score of 36/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -169.0% (sector avg: 5.3%), gross margins of 22.0% (sector avg: 59.6%), net margins of -36.4% (sector avg: 2.3%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
FTRE's value score of 51/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include an EV/EBITDA of 23.10x, a P/B ratio of 1.75x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
Fortrea Holdings Inc.'s investment score of 31/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 5.9% vs. a sector average of 7.8% and a return on assets of -35.8% (sector: 1.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
FTRE shows strong momentum characteristics with a score of 75/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at 5.9% year-over-year, while a beta of 2.01 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
Fortrea Holdings Inc. registers a low stability score of 22/100, indicating high volatility and potentially stressed financial conditions. Key stability metrics include a beta of 2.01 and a debt-to-equity ratio of 372.00x (sector avg: 0.3x). Stocks at this level carry elevated capital loss risk and may be unsuitable for conservative portfolios without careful risk management.
Fortrea Holdings Inc.'s short interest score of 20/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include high market sensitivity (beta: 2.01), elevated leverage (D/E: 372.00x), small-cap liquidity risk. At $765M (small-cap), FTRE carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
Fortrea Holdings Inc. is a small-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #2876 of 7,333 overall (61st percentile). Key comparisons include ROE of -169.0% trailing the 5.3% sector median and operating margins of -32.6% below the 3.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While FTRE currently exhibits a REDUCE profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Short Int. (20) would have the largest impact on the composite score.
EV/EBITDA 97% ABOVE SECTOR MEDIAN
ROE 3283% BELOW SECTOR MEDIAN
Gross Margin 63% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate Fortrea Holdings Inc. (FTRE) as a Reduce with a composite score of 44.6/100 at a current price of $10.33. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential and elevated risk of underperformance relative to peers over the next 12 months.
The rating is primarily driven by strength in momentum (75th percentile) and value (51th percentile), which together account for the majority of the composite score. Offsetting weakness in stability (22th percentile) and investment (31th percentile) tempers our overall conviction. We assign a No Moat rating (15/100), Very High uncertainty, and Poor capital allocation.
Key items to watch: balance sheet deleveraging progress; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Fortrea Holdings Inc. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 44.6/100 places it at rank #2876 in our full 7,333-stock universe. At $765M in market capitalization, Fortrea Holdings Inc. is a small-cap player in the Services space, which limits certain scale advantages but may allow for more agile strategic execution.
The outlook is moderately positive, with revenue expanding at 6% and favorable momentum (75th percentile) reflecting constructive market sentiment. The business shows steady execution, though the growth rate is below the levels typically associated with high-conviction growth stories. Momentum confirmation provides support for the current price level.
The margin cascade tells an important story: gross margins of 22% (-37.6pp vs sector) narrow to operating margins of -33% (-36.1pp vs sector) and net margins of -36.4%, yielding a gross-to-net conversion rate of -166%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $10.33, Fortrea Holdings Inc. is trading near fair value based on current fundamentals. Our value factor score of 51/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at EV/EBITDA of 23.1x (at a premium), P/B of 1.8x, P/S of 0.4x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Positive momentum (75th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
The Reduce rating (composite 44.6/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Elevated leverage (372% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Thin net margins of -36.4% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
High beta of 2.01 means amplified losses in market selloffs — in a broad market correction, this stock would likely decline more than the index.
We assign a Very High uncertainty rating to Fortrea Holdings Inc.. The stock exhibits multiple compounding risk factors: elevated market sensitivity (beta of 2.01), significant leverage (372% debt-to-equity), current negative profitability (net margin -36.4%). The extreme uncertainty around future cash flows makes precise valuation difficult, and the range of outcomes is exceptionally wide. Only investors with high risk tolerance and extended time horizons should consider this name.
Specific risk factors that inform our assessment include: elevated market sensitivity (beta of 2.01); significant leverage (372% debt-to-equity); current negative profitability (net margin -36.4%); below-average price stability (22th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 22th percentile and quality factor at the 36th percentile provide a quantitative summary of the overall risk landscape.
We identify limited risk mitigants at this time, which contributes to our very high uncertainty assessment. Investors should monitor for improvement in balance sheet metrics, margin stability, and business predictability that could warrant a downgrade in our risk assessment over time.
We rate Fortrea Holdings Inc.'s capital allocation as Poor. Key concerns include low returns on equity (-169.0%), elevated leverage (372% D/E), negative profitability, weak asset returns (ROA -35.8%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Fortrea Holdings Inc. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Fortrea Holdings Inc. receives a Reduce rating with a composite score of 44.6/100 (rank #2876 of 7,333). Our quantitative framework assigns a No Moat (15/100, trend: stable), Very High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 43/100.
Our analysis does not support a constructive view on Fortrea Holdings Inc. at this time. The combination of limited competitive advantages, very high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign Fortrea Holdings Inc. a meaningful economic moat, scoring 15/100 on our composite assessment. The ROIC-WACC spread of -7.4% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, growth durability, reached only 4.5/20.
The strongest moat sources are growth durability (4.5/20) and economic value creation (4.1/20). Rev growth 6%, 3yr history. ROIC -0.7% vs WACC 6.7% (spread -7.4%). These pillars form the core of Fortrea Holdings Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0.8/20) and financial resilience (2.5/20). Capital turnover 0.70x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Fortrea Holdings Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include moderate revenue growth of 6%. The margin cascade from 22% gross to -33% operating to -36.4% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 36th percentile.
The margin profile shows gross margins of 22%, operating margins of -33%, net margins of -36.4%. Return metrics include ROE of -169.0% and ROA of -35.8%. Relative to the Services sector, gross margins are 37.6 percentage points below the sector median of 60%, and ROE of -169.0% compares to a sector median of 5.3%.
The balance sheet reflects high leverage with D/E of 372%, which may limit financial flexibility, revenue growth of 6%. The sector median D/E is 0%, putting Fortrea Holdings Inc. at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
Above 50MA
37.18%
Net New Highs
+51081
Adds to executive focus on early clinical development and deepens medical and scientific partnership with clientsDURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has expanded its executive team. Oren Cohen, MD who previously served as both Fortrea’s chief medical officer (CMO) and president of Clinical Pharmacology Services (CPS) is now dedicated to his CMO responsibilities, namely me

Fortrea Holdings reported Q2 2025 revenue of $710.3 million, beating analyst estimates by 12.5%. Despite positive revenue growth and improved adjusted earnings, the company faced challenges including a significant goodwill impairment and a book-to-bill ratio below target.
Over the past six months, Fortrea has been a great trade, beating the S&P 500 by 28.1%. Its stock price has climbed to $10.64, representing a healthy 34.8% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
On 17 February 2026, Fortrea Holdings expanded its executive team by dedicating Oren Cohen, MD solely to the chief medical officer role and appointing Scott Dove, PhD as president of Clinical Pharmacology Services, with both serving on the Executive Committee. This leadership reshaping concentrates seasoned medical and early development expertise at the top of the organization, potentially affecting how Fortrea runs trials and manages its clinical pharmacology operations. Next, we’ll examine...